Enzo Biochem (ENZ) Reports Q2 EPS of $0.09, CEO to Step Down

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. SPY
9. XYZ
10. FISV

Go back to Enzo Biochem (ENZ) Reports Q2 EPS of $0.09, CEO to Step Down

Enzo Biochem Reports Second Quarter Fiscal 2021 Results; Company Provides Leadership and Corporate Updates

March 15, 2021 4:05 PM EDT

Total second quarter revenue of $31.5 million increased 62% year-over-year on continued recovery and expansion from impact of COVID-19 pandemicSecond quarter clinical laboratory revenue of $24.0 million increased 92% on significant volume and pricing growth due to improved product mix Consolidated quarterly gross margin of 50% improved 2000 basis points year-over-yearAchieved adjusted EBITDA at $4.3 million for the quarter with increases in sequential and YOY profitabilityEPS of $0.05 for the quarter vs. EPS loss of ($0.16) in Q2 2020Dr. Elazar Rabbani, Founder and CEO, to step down as CEO and transition... More